18,587 articles
Paola D Vermeer
Paola D Vermeer is an American cancer biologist who heads the Vermeer Lab at Sanford Research in Sioux Falls, South Dakota, studying how nerves recruited by tumors affect immunity.
Paola Picotti
Paola Picotti is a proteomics scientist and Full Professor of Molecular Systems Biology at ETH Zurich since 2023, known for the LiP-MS method and Parkinson's disease research.
Paola Scaffidi
Paola Scaffidi is a cancer epigenetics researcher who leads a group at the European Institute of Oncology in Milan, known for her work on HMGB1, progeria, and phenotypic inertia.
Paolo A. Ascierto
Paolo A. Ascierto, also known as Paolo Antonio Ascierto, is an Italian medical oncologist who led melanoma and immunotherapy research at the Istituto Nazionale Tumori in Naples.
Paolo Bernardi
Paolo Bernardi is an Italian professor of general pathology at the University of Padova, a pioneer of mitochondrial physiology known for work on the permeability transition pore.
Paolo Boffetta
Paolo Boffetta is an Italian cancer epidemiologist who studies how tobacco, alcohol, occupation, and environment affect cancer risk, and teaches at the University of Bologna.
Paolo Calabresi
Paolo Calabresi is an Italian neurologist and full professor at the Università Cattolica del Sacro Cuore in Rome, known for work on striatal synaptic plasticity in Parkinson's disease.
Paolo Casali
Paolo Casali is an Italian-born immunologist at UT Health San Antonio known for work on class-switch recombination, somatic hypermutation, and a humanized mouse mounting human antibody responses.
Paolo Fusar-Poli
Paolo Fusar-Poli is an Italian psychiatrist and Professor of Preventive Psychiatry at King's College London, known for research on detecting and preventing psychosis before the first episode.
Paolo G. Camici
Paolo G. Camici is an Italian cardiologist and physician-scientist who characterized coronary microvascular dysfunction and hibernating myocardium, and is Professor of Cardiology at Università Vita-Salute San Raffaele in Milan.
Paolo Golino
Paolo Golino is an Italian cardiologist and physician-scientist, Professor of Cardiology at the University of Campania and Chief of Cardiology at the Monaldi Hospital in Naples since 2018.
Paolo Lusso
Paolo Lusso is an Italian-born virologist and immunologist, chief of the Viral Pathogenesis Section at NIAID in Bethesda, Maryland, known for HIV and herpesvirus research.
Paolo M. Comoglio
Paolo M. Comoglio, also known as Paolo Maria Comoglio, is an Italian molecular oncologist who identified the MET and RON receptors and introduced the concept of invasive growth.
Paolo Prandoni
Paolo Prandoni, born in 1947, is an Italian physician and thrombosis researcher at the University of Padua known for advancing venous thromboembolism diagnosis and treatment.
Paolo Sassone-Corsi
Paolo Sassone-Corsi (1956–2020) was an Italian-born molecular biologist at UC Irvine who showed how the circadian clock is built into chromosomes and metabolism, notably proving the clock protein CLOCK is a chromatin-modifying enzyme.
Paolo Spirito
Paolo Spirito is an Italian cardiologist at Policlinico di Monza known for research on hypertrophic cardiomyopathy, including his landmark 2000 study linking wall thickness to sudden-death risk.
Paolo Vineis
Paolo Vineis is an Italian physician and cancer epidemiologist who holds the Chair of Environmental Epidemiology at Imperial College London, working in molecular epidemiology and exposomics.
Paramjit S. Arora
Paramjit S. Arora is a Professor of Chemistry at New York University working in chemical biology, known for the hydrogen bond surrogate approach to stabilized α-helices.
Pardis C. Sabeti
Pardis C. Sabeti, also known as Pardis Sabeti, is an Iranian-born American computational geneticist and physician-scientist at the Broad Institute and Harvard, known for genomic work on Ebola and Lassa.
Paresh Vyas
Paresh Vyas is a physician-scientist who is Professor of Haematology at the University of Oxford and leads an MRC Molecular Haematology Unit group studying leukemia stem cells in acute myeloid leukemia.
Parkash S. Gill
Parkash S. Gill is an American oncologist and physician-scientist at USC's Keck School of Medicine, known for Kaposi's sarcoma research and developing three FDA-approved cancer drugs.
Pascal Chanez
Pascal Chanez is a French physician-scientist in respiratory medicine and allergology, professor at Marseille and head of its severe asthma clinic, co-author of the mepolizumab trials DREAM and MENSA.
Pascal Fries
Pascal Fries, born 1972, is a neuroscientist known for the communication-through-coherence hypothesis, built from recordings in visual cortex, leading research groups in Frankfurt and Tübingen.
Pascal Geldsetzer
Pascal Geldsetzer is a physician-scientist and Assistant Professor of Medicine at Stanford whose 2025 Nature study found shingles vaccination reduced dementia diagnoses by about 20%.
Pascal J. Goldschmidt‐Clermont
Pascal J. Goldschmidt-Clermont is a Belgian-trained cardiologist who led cardiology at Duke, directed Ohio State's Heart and Lung Research Institute, and was dean of the University of Miami's medical school from 2006 to 2016.
Pascal Meier
Pascal Meier is a Swiss-trained molecular cell biologist and professor at the Institute of Cancer Research, known for work on inhibitor of apoptosis proteins, cell death, and inflammation.
Pascal Ravassard
Pascal Ravassard is a French neuroscientist, first author of the 2013 Science study showing hippocampal place cells can measure distance, cited in the 2014 Nobel Prize background.
Pascal S. Kaeser
Pascal S. Kaeser, also published as Pascal Kaeser, is a Swiss-born physician-scientist and Professor of Neurobiology at Harvard Medical School who studies active zones and dopamine release.
Pascal Schneider
Pascal Schneider is a Swiss immunologist and senior lecturer at the University of Lausanne whose work on TNF-family proteins produced the 2018 prenatal correction of XLHED.
Pascale Allotey
Pascale Allotey is a global public health researcher who has directed the World Health Organization's Department of Sexual and Reproductive Health and Research since 2022.